People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in ...

In past trials, ketamine intravenous treatment has shown promise, with 64% of depression patients in trials experiencing ...

Apimostinel has a similar mode of action to ketamine and derivatives like Johnson & Johnson's Spravato (esketamine) – ...

It was approved by the FDA in 2008 to treat major depressive disorder, and it was recently approved for teens.

Learn more about anxiety medications. The first line of treatment for depression is antidepressant medication. Some people may need a combination of drugs to best manage their condition.

Focusing treatments for depression and anxiety to gut cells instead of brain cells may help people feel better without side effects.

Depression affects millions of Americans every year, and the challenges can feel even more overwhelming during the holiday ...

In a recent study, transcranial magnetic stimulation was found to be more effective than switching to a new medication for ...

Research reveals new connections between the gut and brain, suggesting more targeted depression and anxiety treatments, and a ...

The drug has shown strong results in phase 3 clinical trials, which are the basis for the new application to the FDA.

Relmada halted Phase 3 trials of NMDA receptor blocker for depression but will continue its early psilocybin program while ...

A systemic review found that, on average, 36 percent of people living with schizophrenia met the criteria for treatment ...